Pharmaceuticals Archives
March 4, 2008
Good Side Affects?
Usually drugs for disease treatment are listed with serious side affects. However, researchers have noted that certain certain drugs for type II diabetes also appear to lower patients' blood pressure. Drugs called thiazolidinediones (TDZs), which are used to treat type... ... morePosted at 9:57 PM | Comments (0) | TrackBack
March 27, 2007
Cardiac Drug may Provide Treatment for Diabetes
Reuters is reporting breaking news about a drug that dramatically reduces the risk of developing diabetes from the American College of Cardiology scientific meeting in New Orleans Although AtheroGenics Inc.'s experimental heart drug actually missed its primary goal during a... ... morePosted at 6:28 PM
October 10, 2006
Appetite-Fighting Molecule May Fight Obesity
Obesity is global epidemic in both developing as well as developed nations, and according to the World Health Organization, of the estimated 1 billion adults worldwide who are overweight, about 300 million are considered obese. Obesity is a major risk... ... morePosted at 3:08 PM
March 2, 2006
Study Says Tequin Could Produce Diabetes
Elderly people who took the medication were 17 times more likely to develop serious diabetes than if they took a different antibiotic
... morePosted at 3:58 PM
January 6, 2006
Diabetes Patients Report Drug Side Effects
Avandia and Avandamet reportedly have caused blurry vision and swelling of the legs and feet of some patients. The information comes from the Food and Drug Administration and manufacturer GlaxoSmithKline. The majority of those patients also reported peripheral edema, or... ... morePosted at 12:25 PM | TrackBack
October 21, 2005
New Diabetes Pill Deemed Dangerous
Peroxisome proliferator–activated receptors (PPARs) are nuclear transcription factors that modulate gene expression. Therapeutic agents targeting 2 distinct families of PPARs ( and ) have been introduced in the United States. The first dual-PPAR agonist, muraglitazar, was reviewed by a US Food and Drug Administration (FDA) advisory committee on September 9, 2005, resulting in a vote of 8:1 recommending approval for its use in controlling blood glucose levels in patients with type 2 diabetes.
... moreSeptember 9, 2005
US Panel Recommends Exubera inhaled insulin
Good news for insulin users: an advisory panel voted 7-2 to urge the Food and Drug Administration to approve an inhaled insulin (Exubera).... ... moreJune 1, 2005
Biovail, Depomed Announce Regulatory Approval of Glumetza to Treat Type II Diabetes in Canada
Glumetza(TM) (metformin hydrochloride) extended-release tablets in 500mg and 1,000mg dosage strengths are indicated for the control of hyperglycemia in adult patients with Type II diabetes (non-insulin-dependant, mature onset), as an adjunct to dietary management, exercise, and weight reduction, or when insulin therapy is not appropriate. Glumetza(TM) may be used as monotherapy, or concomitantly with a sulfonylurea.
... morePosted at 12:17 PM | TrackBack
May 27, 2005
Reports of Blindness Surface Related to use of Viagra
The U.S. Food and Drug Administration said it has received about 38 reports of the rare condition among users of Viagra, four reports of blindness among users of Eli Lilly and Co.'s Cialis and one report of the condition in... ... morePosted at 11:59 AM | TrackBack
May 13, 2005
Byetta (exenatide) Continues to Make the News
The latest story is from Reuters:For people with type 2 diabetes whose blood sugar is inadequately controlled when they're on two oral anti-diabetes medicines, the addition of an injected drug called exenatide is helpful, researchers report. Dr. Alain D. Baron... ... morePosted at 12:12 PM | TrackBack
May 7, 2005
Firms Compete for future Inhaled-Insulin Market
In the coming months and years, pharmaceutical giants such as Eli Lilly , Pfizer and Sanofi-Aventis will seek approval for these new insulin-delivery devices -- similar to the contraptions used by asthma patients. The first products could hit the market by early 2006.
... morePosted at 12:00 PM | TrackBack
April 29, 2005
FDA has approved a diabetes drug derived from lizard saliva
The FDA has approved a diabetes drug derived from lizard saliva for patients who have not responded to other treatments. Exenatide, developed by Eli Lilly and Co. and Amylin Pharmaceuticals Inc., is an injectable drug to be sold under the... ... morePosted at 12:15 PM | TrackBack
April 25, 2005
Inhaled Insulin Said to Be 'Safe' and 'Effective'
Test results presented at the Diabetes UK annual conference in Glasgow showed that for people with Type 2 diabetes already on tablets, inhaled insulin gave better blood glucose control than taking more tablets as treatment. Among patients with Type 1... ... moreApril 22, 2005
Diabetes drug 'may stop cancers'
A drug commonly used to treat Type 2 diabetes may prevent cancer, researchers have said. The team studied cancer rates among 6,000 people with diabetes and found those who took metformin cut their risk of all tumour types by more... ... moreApril 20, 2005
Inhaled Insulin - Promising but Questions Remain
The Guardian reports what could be a press release from a Pharmaceutical company:Hundreds of thousands of people with diabetes may soon benefit from inhalers that could dramatically cut the number of injections needed to control the disease. Researchers believe the... ... morePosted at 7:50 AM